• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Medical therapy for pediatric pulmonary arterial hypertension.

作者信息

Tissot Cecile, Ivy David Dunbar, Beghetti Maurice

机构信息

Pediatric Cardiology Unit, The Children's University Hospital of Geneva, Geneva, Switzerland.

出版信息

J Pediatr. 2010 Oct;157(4):528-32. doi: 10.1016/j.jpeds.2010.06.010. Epub 2010 Jul 24.

DOI:10.1016/j.jpeds.2010.06.010
PMID:20656296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3127257/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef4/3127257/885dfd7640d3/nihms300911f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef4/3127257/885dfd7640d3/nihms300911f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cef4/3127257/885dfd7640d3/nihms300911f1.jpg

相似文献

1
Medical therapy for pediatric pulmonary arterial hypertension.小儿肺动脉高压的药物治疗
J Pediatr. 2010 Oct;157(4):528-32. doi: 10.1016/j.jpeds.2010.06.010. Epub 2010 Jul 24.
2
Pulmonary arterial hypertension in children: a medical update.儿童肺动脉高压：医学进展
Indian J Pediatr. 2009 Jan;76(1):77-81. doi: 10.1007/s12098-009-0032-2. Epub 2009 Apr 18.
3
Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension.5型磷酸二酯酶抑制：肺动脉高压的前景疗法。
Intern Med. 2004 Oct;43(10):891-3. doi: 10.2169/internalmedicine.43.891.
4
[Pulmonary arterial hypertension. New therapeutic principles improve treatment of a rare condition].[肺动脉高压。新的治疗原则改善了一种罕见疾病的治疗]
Lakartidningen. 2009;106(34):2057-61.
5
Treatment of pulmonary arterial hypertension: a step forward.肺动脉高压的治疗：向前迈进的一步。
Chest. 2003 Jul;124(1):8-11. doi: 10.1378/chest.124.1.8.
6
Pulmonary hypertension in older children: new approaches and therapies.大龄儿童肺动脉高压：新方法与治疗手段
Paediatr Respir Rev. 2006;7 Suppl 1:S177-9. doi: 10.1016/j.prrv.2006.04.210. Epub 2006 Jun 5.
7
Prostacyclin-analog therapy in sickle cell pulmonary hypertension.前列环素类似物疗法治疗镰状细胞性肺动脉高压
Haematologica. 2017 May;102(5):e163-e165. doi: 10.3324/haematol.2015.131227. Epub 2017 Jan 25.
8
[Diagnosis and treatment of pulmonary hypertension].[肺动脉高压的诊断与治疗]
Pneumologie. 2006 Jul;60(7):428-40; quiz 441-2. doi: 10.1055/s-2006-932217.
9
Medical therapy for pulmonary arterial hypertension.肺动脉高压的药物治疗。
Expert Opin Pharmacother. 2008 Jan;9(1):65-81. doi: 10.1517/14656566.9.1.65.
10
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.美国心脏病学会基金会专家共识文件工作组与美国心脏协会合作制定的2009年ACCF/AHA肺动脉高压专家共识文件，与美国胸科医师学会、美国胸科学会以及肺动脉高压协会共同完成。
J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619. doi: 10.1016/j.jacc.2009.01.004.

引用本文的文献

1
Treatment of pulmonary arterial hypertension in children.儿童肺动脉高压的治疗
Cardiovasc Diagn Ther. 2021 Aug;11(4):1144-1159. doi: 10.21037/cdt-20-912.
2
Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.小儿肺动脉高压：定义、机制、诊断与治疗。
Compr Physiol. 2021 Jun 30;11(3):2135-2190. doi: 10.1002/cphy.c200023.
3
Drug Treatment of Pulmonary Hypertension in Children.儿童肺动脉高压的药物治疗。
Paediatr Drugs. 2020 Apr;22(2):123-147. doi: 10.1007/s40272-019-00374-2.
4
Management of Persistent Pulmonary Hypertension After Correction of Congenital Heart Defect with Autologous Marrow-Derived Mononuclear Stem Cell Injection into the Pulmonary Artery: A Pilot Study.先天性心脏病矫正术后经肺动脉注射自体骨髓来源的单个核干细胞治疗持续性肺动脉高压：一项初步研究
Pediatr Cardiol. 2020 Feb;41(2):398-406. doi: 10.1007/s00246-019-02273-2. Epub 2020 Jan 7.
5
The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis.内皮素受体拮抗剂波生坦治疗先天性心脏病相关肺动脉高压的疗效：一项系统评价和荟萃分析。
Medicine (Baltimore). 2018 Mar;97(10):e0075. doi: 10.1097/MD.0000000000010075.
6
Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.2000年至2009年美国儿童肺动脉高压相关住院情况的趋势
Pulm Circ. 2015 Jun;5(2):339-48. doi: 10.1086/681226.
7
Use of inhaled iloprost for the management of postoperative pulmonary hypertension in congenital heart surgery patients: review of a transition protocol.吸入伊洛前列素用于先天性心脏病手术患者术后肺动脉高压管理：过渡方案综述
Pediatr Cardiol. 2014 Dec;35(8):1337-43. doi: 10.1007/s00246-014-0933-3. Epub 2014 May 29.
8
Drug treatment of pulmonary hypertension in children.儿童肺动脉高压的药物治疗。
Paediatr Drugs. 2014 Feb;16(1):43-65. doi: 10.1007/s40272-013-0052-2.
9
Diagnosis and treatment of pulmonary hypertension in infancy.婴幼儿肺动脉高压的诊断与治疗。
Early Hum Dev. 2013 Nov;89(11):865-74. doi: 10.1016/j.earlhumdev.2013.09.012. Epub 2013 Sep 29.
10
Current challenges in pediatric pulmonary hypertension.小儿肺动脉高压的当前挑战。
Semin Respir Crit Care Med. 2013 Oct;34(5):627-44. doi: 10.1055/s-0033-1356461. Epub 2013 Sep 13.

本文引用的文献

1
Non-congenital heart disease associated pediatric pulmonary arterial hypertension.非先天性心脏病相关的小儿肺动脉高压
Prog Pediatr Cardiol. 2009 Dec 1;27(1-2):13-23. doi: 10.1016/j.ppedcard.2009.09.004.
2
Pulmonary arterial hypertension in children: Diagnostic work-up and challenges.儿童肺动脉高压：诊断检查与挑战
Prog Pediatr Cardiol. 2009 Dec;27(1):4-11. doi: 10.1016/j.ppedcard.2009.09.003.
3
Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France.法国肺动脉高压患儿的特征及 2 年前瞻性随访。
Arch Cardiovasc Dis. 2010 Feb;103(2):66-74. doi: 10.1016/j.acvd.2009.12.001. Epub 2010 Feb 11.
4
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 study.新型波生坦制剂在肺动脉高压儿童患者中的药代动力学和临床特征：FUTURE-1 研究。
Br J Clin Pharmacol. 2009 Dec;68(6):948-55. doi: 10.1111/j.1365-2125.2009.03532.x.
5
Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension.静脉注射西地那非治疗持续性肺动脉高压的新生儿。
J Pediatr. 2009 Dec;155(6):841-847.e1. doi: 10.1016/j.jpeds.2009.06.012.
6
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).肺动脉高压诊断和治疗指南：欧洲心脏病学会（ESC）和欧洲呼吸学会（ERS）肺动脉高压诊断和治疗工作组，得到国际心肺移植学会（ISHLT）认可。
Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27.
7
Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.具有保护连接的封闭枢纽系统与接受静脉注射前列环素治疗肺动脉高压的儿科患者导管相关血流感染风险的降低
Infect Control Hosp Epidemiol. 2009 Sep;30(9):823-9. doi: 10.1086/605320.
8
Updated evidence-based treatment algorithm in pulmonary arterial hypertension.肺动脉高压的最新循证治疗算法
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S78-S84. doi: 10.1016/j.jacc.2009.04.017.
9
Diagnosis and assessment of pulmonary arterial hypertension.肺动脉高压的诊断与评估
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S55-S66. doi: 10.1016/j.jacc.2009.04.011.
10
Updated clinical classification of pulmonary hypertension.肺动脉高压的更新临床分类。
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54. doi: 10.1016/j.jacc.2009.04.012.